Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129135057> ?p ?o ?g. }
- W2129135057 endingPage "343" @default.
- W2129135057 startingPage "330" @default.
- W2129135057 abstract "We reassessed the Clinical and Laboratory Standards Institute (CLSI) clinical breakpoints (CBPs) for voriconazole. We examined i) the essential (EA: ±2 dilutions) and categorical agreement between 24-h CLSI and EUCAST methods for voriconazole testing of Candida, ii) wild-type (WT) MICs and epidemiologic cutoff values (ECVs) for voriconazole by both CLSI and EUCAST methods, and iii) correlation of MICs with outcomes from previously published data using CLSI methods. We applied these findings to propose new 24-h species-specific CLSI CBPs. Adjusted 24-h CBPs for voriconazole and C. albicans, C. tropicalis, and C. parapsilosis (susceptible, ≤ 0.125 μg/mL; intermediate, 0.25-0.5 μg/mL; resistant, ≥ 1 μg/mL) should be more sensitive for detecting emerging resistance among common Candida species and provide consistency with EUCAST CBPs. In the absence of CBPs for voriconazole and C. glabrata (and less common species), we recommend that their respective ECVs be used to detect the emergence of non-WT strains." @default.
- W2129135057 created "2016-06-24" @default.
- W2129135057 creator A5002306472 @default.
- W2129135057 creator A5014003209 @default.
- W2129135057 creator A5019407143 @default.
- W2129135057 creator A5026380383 @default.
- W2129135057 creator A5028081249 @default.
- W2129135057 creator A5028256879 @default.
- W2129135057 creator A5039745586 @default.
- W2129135057 creator A5046372032 @default.
- W2129135057 creator A5063196803 @default.
- W2129135057 creator A5066654372 @default.
- W2129135057 creator A5071800632 @default.
- W2129135057 creator A5075694346 @default.
- W2129135057 creator A5088543425 @default.
- W2129135057 creator A5089366807 @default.
- W2129135057 creator A5089635085 @default.
- W2129135057 date "2011-07-01" @default.
- W2129135057 modified "2023-10-03" @default.
- W2129135057 title "Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria" @default.
- W2129135057 cites W1546412707 @default.
- W2129135057 cites W1559027872 @default.
- W2129135057 cites W1897020142 @default.
- W2129135057 cites W1967632969 @default.
- W2129135057 cites W1975475744 @default.
- W2129135057 cites W1995170603 @default.
- W2129135057 cites W1998771714 @default.
- W2129135057 cites W2009317938 @default.
- W2129135057 cites W2017248809 @default.
- W2129135057 cites W2020586027 @default.
- W2129135057 cites W2023123671 @default.
- W2129135057 cites W2025498860 @default.
- W2129135057 cites W2025563268 @default.
- W2129135057 cites W2027962943 @default.
- W2129135057 cites W2029714817 @default.
- W2129135057 cites W2046034819 @default.
- W2129135057 cites W2053731121 @default.
- W2129135057 cites W2058909715 @default.
- W2129135057 cites W2061567342 @default.
- W2129135057 cites W2070655297 @default.
- W2129135057 cites W2075439470 @default.
- W2129135057 cites W2076094587 @default.
- W2129135057 cites W2082695689 @default.
- W2129135057 cites W2084643045 @default.
- W2129135057 cites W2087548480 @default.
- W2129135057 cites W2094791075 @default.
- W2129135057 cites W2097149581 @default.
- W2129135057 cites W2097784274 @default.
- W2129135057 cites W2098169836 @default.
- W2129135057 cites W2099816638 @default.
- W2129135057 cites W2100626246 @default.
- W2129135057 cites W2104218588 @default.
- W2129135057 cites W2105638437 @default.
- W2129135057 cites W2106962923 @default.
- W2129135057 cites W2113460689 @default.
- W2129135057 cites W2114943619 @default.
- W2129135057 cites W2115130703 @default.
- W2129135057 cites W2115831228 @default.
- W2129135057 cites W2118836068 @default.
- W2129135057 cites W2120099116 @default.
- W2129135057 cites W2122716163 @default.
- W2129135057 cites W2128233423 @default.
- W2129135057 cites W2129968846 @default.
- W2129135057 cites W2132112261 @default.
- W2129135057 cites W2132582794 @default.
- W2129135057 cites W2133826036 @default.
- W2129135057 cites W2136619689 @default.
- W2129135057 cites W2137351193 @default.
- W2129135057 cites W2137575148 @default.
- W2129135057 cites W2138433856 @default.
- W2129135057 cites W2139126851 @default.
- W2129135057 cites W2139596056 @default.
- W2129135057 cites W2142813751 @default.
- W2129135057 cites W2145813802 @default.
- W2129135057 cites W2147356875 @default.
- W2129135057 cites W2147418284 @default.
- W2129135057 cites W2147673521 @default.
- W2129135057 cites W2148641130 @default.
- W2129135057 cites W2150428940 @default.
- W2129135057 cites W2154030470 @default.
- W2129135057 cites W2156802863 @default.
- W2129135057 cites W2158530375 @default.
- W2129135057 cites W2158961122 @default.
- W2129135057 cites W2164001967 @default.
- W2129135057 cites W2167143090 @default.
- W2129135057 cites W2170975984 @default.
- W2129135057 cites W2310654154 @default.
- W2129135057 cites W2314681583 @default.
- W2129135057 doi "https://doi.org/10.1016/j.diagmicrobio.2011.03.002" @default.
- W2129135057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21546199" @default.
- W2129135057 hasPublicationYear "2011" @default.
- W2129135057 type Work @default.
- W2129135057 sameAs 2129135057 @default.
- W2129135057 citedByCount "121" @default.
- W2129135057 countsByYear W21291350572012 @default.
- W2129135057 countsByYear W21291350572013 @default.
- W2129135057 countsByYear W21291350572014 @default.
- W2129135057 countsByYear W21291350572015 @default.